Skip to main content
. 2020 Jul 1;10:10727. doi: 10.1038/s41598-020-67535-z

Table 2.

In vitro effects of the exposure to BDNF on the expression of genes involved in glucose and lipid transport and metabolism and of key transcription factors in ZFL cells.

1 h 6 h
Control BDNF
0.1 nM
BDNF
1 nM
BDNF
10 nM
Control BDNF
0.1 nM
BDNF
1 nM
BDNF
10 nM
Glucose transport and metabolism
Transport:
 glut2 1.00 ± 0.11a 1.52 ± 0.59ab 2.55 ± 0.24b 5.07 ± 0.84c 1.00 ± 0.20a 1.53 ± 0.23ab 1.75 ± 0.30b 2.28 ± 0.15b
 sglt1 1.00 ± 0.24a 2.82 ± 0.03b 3.92 ± 0.74bc 5.91 ± 0.39c 1.00 ± 0.08a 1.90 ± 0.09b 1.95 ± 0.35b 2.42 ± 0.41b
Glycolysis:
 gck 1.00 ± 0.11a 1.46 ± 0.06b 2.02 ± 0.25b 3.48 ± 0.59c 1.00 ± 0.09a 1.79 ± 0.10b 1.85 ± 0.12b 2.24 ± 0.56b
 pfkla 1.00 ± 0.11 1.00 ± 0.15 1.08 ± 0.08 0.71 ± 0.31 1.00 ± 0.10 1.10 ± 0.19 1.38 ± 0.38 0.81 ± 0.21
 pfklb 1.00 ± 0.15 1.63 ± 0.05 1.11 ± 0.13 0.98 ± 0.38 1.00 ± 0.06 1.03 ± 0.23 0.99 ± 0.24 1.12 ± 0.17
 pklr 1.00 ± 0.25a 1.52 ± 0.20ab 2.37 ± 0.35b 5.79 ± 0.42c 1.00 ± 0.10a 2.13 ± 0.06b 1.75 ± 0.18b 2.66 ± 0.37b
Gluconeogenesis:
 pck1 1.00 ± 0.29 1.02 ± 0.24 1.34 ± 0.29 0.61 ± 0.30 1.00 ± 0.10 1.12 ± 0.05 0.95 ± 0.18 1.05 ± 0.39
 pck2 1.00 ± 0.04a 2.10 ± 0.13b 2.09 ± 0.16b 1.99 ± 0.13b 1.00 ± 0.02a 2.34 ± 0.19b 1.90 ± 0.21b 2.49 ± 0.30b
 fbp1a 1.00 ± 0.21a 1.80 ± 0.47ab 2.22 ± 0.22b 3.72 ± 0.40b 1.00 ± 0.05a 1.63 ± 0.19b 1.77 ± 0.04b 1.98 ± 0.18b
 fbp1b 1.00 ± 0.07a 1.76 ± 0.19b 1.48 ± 0.28ab 1.06 ± 0.41ab 1.00 ± 0.03 1.11 ± 0.19 0.94 ± 0.08 1.19 ± 0.15
 g6pcb 1.00 ± 0.25a 2.06 ± 0.38b 1.97 ± 0.21b 4.05 ± 0.54c 1.00 ± 0.13a 4.08 ± 0.70b 2.14 ± 0.19c 3.66 ± 0.39b
Glycogenolysis:
 glycogen phosphorylase 1.00 ± 0.19a 1.70 ± 0.13b 1.98 ± 0.20b 2.23 ± 0.21b 1.00 ± 0.12a 1.90 ± 0.23b 2.11 ± 0.28b 3.11 ± 0.36b
Lipid metabolism
Fatty acid synthesis:
 acly 1.00 ± 0.09a 1.10 ± 0.18a 3.11 ± 0.29b 3.38 ± 0.25b 1.00 ± 0.08a 1.01 ± 0.17ab 1.42 ± 0.18b 3.13 ± 0.34c
 acaca 1.00 ± 0.11a 1.07 ± 0.22a 2.91 ± 0.31b 2.06 ± 0.15b 1.00 ± 0.07a 0.97 ± 0.16a 1.60 ± 0.27b 1.86 ± 0.25b
 fasn 1.00 ± 0.12a 1.84 ± 0.31b 1.48 ± 0.22b 1.73 ± 0.35b 1.00 ± 0.24a 2.18 ± 0.44b 3.00 ± 0.41b 2.96 ± 0.41b
Β-oxidation:
 cpt1a 1.00 ± 0.14a 1.12 ± 0.09a 1.81 ± 0.23b 1.99 ± 0.15b 1.00 ± 0.08a 0.79 ± 0.13a 1.84 ± 0.15b 1.81 ± 0.28b
 acadm 1.00 ± 0.15a 0.61 ± 0.06b 0.66 ± 0.07b 0.62 ± 0.08b 1.00 ± 0.07a 0.62 ± 0.11b 1.01 ± 0.09a 0.94 ± 0.07a
 echs1 1.00 ± 0.08a 0.86 ± 0.09ab 0.67 ± 0.04b 0.73 ± 0.07b 1.00 ± 0.09a 0.80 ± 0.07ab 0.77 ± 0.08b 0.62 ± 0.04b
 hadh 1.00 ± 0.06a 0.99 ± 0.05a 0.77 ± 0.04b 0.78 ± 0.03b 1.00 ± 0.07a 0.83 ± 0.09ab 0.88 ± 0.09ab 0.65 ± 0.04b
Ketogenesis:
 hmgcl 1.00 ± 0.30a 1.79 ± 0.37a 5.46 ± 1.00b 6.73 ± 1.43b 1.00 ± 0.11a 2.63 ± 0.60ab 3.03 ± 0.47b 5.42 ± 0.94c
 acat1 1.00 ± 0.09a 0.92 ± 0.08ab 1.55 ± 0.17b 2.77 ± 0.35c 1.00 ± 0.13a 1.30 ± 0.28a 2.74 ± 0.47b 4.03 ± 0.50c
Transcriptional regulators
ppargc1α 1.00 ± 0.21a 1.72 ± 0.50ab 2.77 ± 0.35bc 3.71 ± 0.43c 1.00 ± 0.14a 2.30 ± 0.32b 2.35 ± 0.35b 2.41 ± 0.24b
pparα 1.00 ± 0.21a 1.51 ± 0.09b 2.38 ± 0.19c 2.42 ± 0.23c 1.00 ± 0.16a 1.99 ± 0.26b 1.69 ± 0.14b 2.23 ± 0.24b

Cells were incubated with culture media alone (control) or containing 0.1, 1 and 10 nM BDNF during 1 and 6 h. Data obtained by RT-qPCR are shown as mean + SEM of the results obtained in two different experiments (n = 6 in each experiment). Different letters indicate significant differences (p < 0.05) among groups within each time point assessed by one-way ANOVA and SNK test.

acaca, acetyl-CoA carboxylase; acadm, acyl-CoA dehydrogenase medium-chain; acat1, acetyl-CoA acetyltransferase 1; acly, ATP citrate lyase; BDNF, brain-derived neurotrophic factor; cpt1a, carnitine palmitoyltransferase 1a; echs1, enoyl-CoA hydratase short-chain 1; fasn, fatty acid synthase; fbp1a, fructose 1,6-bisphosphatase 1a; fbp1b, fructose 1,6-bisphosphatase 1b; g6pcb, glucose 6-phosphatase b; gck, glucokinase; glut2, glucose transporter 2; hadh, 3-hydroxyacyl CoA dehydrogenase; hmgcl, 3-hydroxy-3-methylglutaryl-CoA lyase; pck1, phosphoenolpyruvate carboxykinase 1; pck2, phosphoenolpyruvate carboxykinase 2; pfkla, phosphofructokinase a; pfklb, phosphofructokinase b; pklr, pyruvate kinase; pparα, peroxisome proliferator-activated receptor alpha; ppargc1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; sglt1, sodium-glucose cotransporter 1.